BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29663270)

  • 1. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY; Cho JH; Kim GY; Mansfield BC
    J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY; Jun HS; Mansfield BC
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.
    Chou JY; Jun HS; Mansfield BC
    Nat Rev Endocrinol; 2010 Dec; 6(12):676-88. PubMed ID: 20975743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY; Matern D; Mansfield BC; Chen YT
    Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-directed gene therapy for murine glycogen storage disease type Ib.
    Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for type I glycogen storage diseases.
    Chou JY; Mansfield BC
    Curr Gene Ther; 2007 Apr; 7(2):79-88. PubMed ID: 17430128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of type 1 glycogen storage diseases.
    Chou JY
    Curr Mol Med; 2001 Mar; 1(1):25-44. PubMed ID: 11899241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia in type Ib glycogen storage disease.
    Chou JY; Jun HS; Mansfield BC
    Curr Opin Hematol; 2010 Jan; 17(1):36-42. PubMed ID: 19741523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
    Yiu WH; Pan CJ; Mead PA; Starost MF; Mansfield BC; Chou JY
    J Hepatol; 2009 Nov; 51(5):909-17. PubMed ID: 19376605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
    Kim SY; Jun HS; Mead PA; Mansfield BC; Chou JY
    Blood; 2008 Jun; 111(12):5704-11. PubMed ID: 18420828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
    Yiu WH; Pan CJ; Allamarvdasht M; Kim SY; Chou JY
    Gene Ther; 2007 Feb; 14(3):219-26. PubMed ID: 17006547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SLC37 family of sugar-phosphate/phosphate exchangers.
    Chou JY; Mansfield BC
    Curr Top Membr; 2014; 73():357-82. PubMed ID: 24745989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
    Lee YM; Kim GY; Pan CJ; Mansfield BC; Chou JY
    Mol Genet Metab Rep; 2015 Jun; 3():28-32. PubMed ID: 26937391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SLC37 family of phosphate-linked sugar phosphate antiporters.
    Chou JY; Sik Jun H; Mansfield BC
    Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
    Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
    FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
    Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
    Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent development and gene therapy for glycogen storage disease type Ia.
    Chou JY; Kim GY; Cho JH
    Liver Res; 2017 Sep; 1(3):174-180. PubMed ID: 29576889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of type 1 glycogen storage disease.
    Janecke AR; Mayatepek E; Utermann G
    Mol Genet Metab; 2001 Jun; 73(2):117-25. PubMed ID: 11386847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
    Chen LY; Pan CJ; Shieh JJ; Chou JY
    Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.